Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/14/2021 37 37
Naringin Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021 4 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/05/2021 72 13
BNT162b2 Emergency use authorization Experimental Vaccine Dec/11/2020 5 0
Glycyrrhizic acid Potential treatment - theoretical effect Natural product Antiviral Dec/09/2020 3 0
Simeprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/02/2020 9 1
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Nov/25/2020 19 5
Teniposide Potential treatment - theoretical effect Experimental Antiviral Nov/05/2020 2 0
Eculizumab Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/04/2020 2 0
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/18/2020 10 0